Global Robotic Angiography Systems Market Overview

The Global Robotic Angiography Systems Market Is Expected To Grow At A Significant Growth Rate, And The Analysis Period Is 2022-2028, Considering The Base Year As 2021.

Angiography or arteriography can be described as an imaging technique that is used in the medical area to visualize the inside, or lumen, of blood vessels and organs of the body, such as the arteries, veins, and heart chambers. In the procedure, a radio-opaque contrast agent is injected into the blood vessel and imaging is done using scanning techniques such as fluoroscopy. The recorded film or image of the blood vessels is called an angiograph, or more commonly an angiogram. Further, the automated systems that are used to conduct the angiography of a patient are called Robotic Angiography Systems.

Today, Robotic systems assist the interventionalist in performing cTACE (Conventional TACE) and other procedures. The system consists of joysticks and touchscreen controls that allow a high degree of precision while performing medical procedures. Several advancements in the applications of robots and other automated systems in healthcare have led to the development of Robotic Angiography to assist and help clinicians with challenges by providing guidance for the treatment and 3D imaging tools. The market of Robotic Angiography Systems is emerging at a healthy rate as the major market players are coming up with advanced medical solutions to cover clinical areas including Coronary Artery Disease, Structural Heart Disease, Congenital Heart Disease, Oncology Interventions, Neuro Interventions, Peripheral and Vascular Angiography, and Arrhythmias among others. Also, with the globally rising number of chronic diseases and a prevalence of heart-related and tumor diseases, such patients are advised to get an angiography to diagnose the condition. Moreover, high precision, speed, image quality, and greater access to areas under operation allowed by the Robotic Angiography Systems are influencing the growth in the demand for such automated systems.

Market Dynamics And Factors For Robotic Angiography Systems Market

Drivers:

• Rising Cases of Chronic Diseases Related to Heart, Kidney, and Tumors
• Higher Application Due to Benefits Like increased Procedural Precision and Improved Efficiency in Clinical Care

Restraints:

• Errors Caused Due to The Anatomical Complexity with Variability in Human Operative Methods
• Relatively Low Adoption of These Techniques and Procedures

Opportunity:

• Rising Advancements with The Help of R&D and Government Support for The Development of innovative Medical Equipment and Technologies

Challenges:

• High Angiography Procedures Costs and The High Prices of Robotic Angiography Devices

Regional Analysis In Robotic Angiography Systems Market

Robotic Angiography Systems are gaining greater popularity in North America Region due to several disorders and complications that affect blood vessels, heart, brain kidneys, etc. In Developed Countries of North America, the changing lifestyle habits and unhealthy day-to-day practices are posing a greater risk of diseases like coronary artery and valvular heart diseases, tumors, and others where surgical procedures are highly necessary. Due to this reason the need for high-precision imaging solutions in performing such surgeries is been increasingly adopted to minimize errors and threats. Further, the regional market of Robotic Angiography Systems in North America, other than the burden of cardiovascular disease is driven by the demand for more sophisticated products, the need for the most advanced is pushing the manufacturers to continuously work on their Research and Development functions. To be explained with an example, GE Healthcare the top-performing player in global medical technology in 2016 integrated its new GE’s Discovery IGS 730 angiography system with the Magnus operating table system to achieve greater flexibility, further in 2020 the company again launched its Allia IGS 7 system, an upgraded version of the previous that uses AI-optimized dose and imaging settings to add ease to rotational angiography, owing to all these reasons the North American Market of Robotic Angiography Systems is estimated to experience huge gains in upcoming years.

Covid-19 Impact Analysis On Robotic Angiography Systems Market

The COVID-19 pandemic has had a negative impact across all Robotic Angiography Systems Markets across the globe. The downfall in the market is attributed to a combination of factors, like reduced sales activity and curtailed number of surgical procedures. After the outbreak of the coronavirus in 2020, COVID-19 cases were considered to be of most emergency, and other medical and surgical procedures were unessential. Due to this all the efforts and resources were managed to aid and accommodate the COVID-19 patients during the start of the pandemic. Cardiovascular procedures experienced severe impact during the pandemic and hence the application of Automated Angiography Systems for the same was also impacted.

However, the market is estimated to gain greater growth in upcoming years as the situation is getting back to normal again as the virus is disappearing. The subsiding effect of COVID-19 and increased demand for the product to perform super-selective procedures and other complex interventions are expected to result in increased profits through increased capital expenditures on imaging technologies and equipment and particularly for robotic angiography systems.

Top Key Players Covered In Robotic Angiography Systems Market

• GE Healthcare(US)
• KUKA (Germany)
• Siemens Healthcare Private Limited (Germany)
• Corindus Inc. (US)
• Philips Healthcare (Netherlands)
• Abbott(US)
• Shimadzu Medical Systems (Japan)
• Canon Medical Systems Corporation. (Japan)
• Boston Scientific Corporation (US)
• Angiodynamics (US)
• Medtronic Plc (Ireland) and Other Major Players.

Key Industry Development In The Robotic Angiography Systems Market

In June 2020, Siemens Healthineers, a leading medical device company introduced angiography system Artis icono ceiling for precise tumor embolization. The all-new Artis icono ceiling system is designed to offer precise 2D and 3D imaging with seamless integration of different systems with a third-party interface by importing and modifying the parameters of third-party software. The system provides three-dimensional (3D) data acquisition at the head as well as from the patient’s side over a complete angular range of 200 degrees helping with precise image reconstruction.

In December 2020, GE Healthcare leading global medical technology and digital solutions company introduced the latest version of its robotic-driven angiography system for image-guided therapy, the new Allia IGS 7 angiography system was first unveiled at the 2020 Radiological Society of North America (RSNA) virtual meeting

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Technology
 3.2 By Application
 3.3 By Indication
 3.4 By End-User

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Robotic Angiography Systems Market by Technology
 5.1 Robotic Angiography Systems Market Overview Snapshot and Growth Engine
 5.2 Robotic Angiography Systems Market Overview
 5.3 X-ray Angiography Systems
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 X-ray Angiography Systems: Geographic Segmentation
 5.4 CT Angiography Systems
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 CT Angiography Systems: Geographic Segmentation
 5.5 MR Angiography Systems
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 MR Angiography Systems: Geographic Segmentation

Chapter 6: Robotic Angiography Systems Market by Application
 6.1 Robotic Angiography Systems Market Overview Snapshot and Growth Engine
 6.2 Robotic Angiography Systems Market Overview
 6.3 Endovascular Angiography
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Endovascular Angiography: Geographic Segmentation
 6.4 Onco-Angiography
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Onco-Angiography: Geographic Segmentation
 6.5 Coronary Angiography
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Coronary Angiography: Geographic Segmentation
 6.6 Neuro-Angiography
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Neuro-Angiography: Geographic Segmentation

Chapter 7: Robotic Angiography Systems Market by Indication
 7.1 Robotic Angiography Systems Market Overview Snapshot and Growth Engine
 7.2 Robotic Angiography Systems Market Overview
 7.3 Valvular Heart Disease
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Valvular Heart Disease: Geographic Segmentation
 7.4 Congestive Heart Failure
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Congestive Heart Failure: Geographic Segmentation
 7.5 Coronary Artery Disease
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Coronary Artery Disease: Geographic Segmentation
 7.6 Congenital Heart Disease
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Congenital Heart Disease: Geographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Geographic Segmentation

Chapter 8: Robotic Angiography Systems Market by End-User
 8.1 Robotic Angiography Systems Market Overview Snapshot and Growth Engine
 8.2 Robotic Angiography Systems Market Overview
 8.3 Specialty Clinics
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size (2016-2028F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Specialty Clinics: Geographic Segmentation
 8.4 Hospitals
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size (2016-2028F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Hospitals: Geographic Segmentation
 8.5 Diagnostic and Imaging Centers
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size (2016-2028F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 Diagnostic and Imaging Centers: Geographic Segmentation
 8.6 Academic and Research Institutes
  8.6.1 Introduction and Market Overview
  8.6.2 Historic and Forecasted Market Size (2016-2028F)
  8.6.3 Key Market Trends, Growth Factors and Opportunities
  8.6.4 Academic and Research Institutes: Geographic Segmentation

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Positioning
  9.1.2 Robotic Angiography Systems Sales and Market Share By Players
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Robotic Angiography Systems Industry Concentration Ratio (CR5 and HHI)
  9.1.6 Top 5 Robotic Angiography Systems Players Market Share
  9.1.7 Mergers and Acquisitions
  9.1.8 Business Strategies By Top Players
 9.2 GE HEALTHCARE (US)
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Operating Business Segments
  9.2.5 Product Portfolio
  9.2.6 Business Performance
  9.2.7 Key Strategic Moves and Recent Developments
  9.2.8 SWOT Analysis
 9.3 KUKA (GERMANY)
 9.4 SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY)
 9.5 CORINDUS INC.
 9.6 PHILIPS HEALTHCARE (NETHERLANDS)
 9.7 ABBOTT (US)
 9.8 SHIMADZU MEDICAL SYSTEMS (JAPAN)
 9.9 CANON MEDICAL SYSTEMS CORPORATION (JAPAN)
 9.10 BOSTON SCIENTIFIC CORPORATION (US)
 9.11 ANGIODYNAMICS (US)
 9.12 MEDTRONIC PLC (IRELAND)
 9.13 OTHER MAJOR PLAYERS

Chapter 10: Global Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 10.1 Market Overview
 10.2 Historic and Forecasted Market Size By Technology
  10.2.1 X-ray Angiography Systems
  10.2.2 CT Angiography Systems
  10.2.3 MR Angiography Systems
 10.3 Historic and Forecasted Market Size By Application
  10.3.1 Endovascular Angiography
  10.3.2 Onco-Angiography
  10.3.3 Coronary Angiography
  10.3.4 Neuro-Angiography
 10.4 Historic and Forecasted Market Size By Indication
  10.4.1 Valvular Heart Disease
  10.4.2 Congestive Heart Failure
  10.4.3 Coronary Artery Disease
  10.4.4 Congenital Heart Disease
  10.4.5 Others
 10.5 Historic and Forecasted Market Size By End-User
  10.5.1 Specialty Clinics
  10.5.2 Hospitals
  10.5.3 Diagnostic and Imaging Centers
  10.5.4 Academic and Research Institutes

Chapter 11: North America Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Technology
  11.4.1 X-ray Angiography Systems
  11.4.2 CT Angiography Systems
  11.4.3 MR Angiography Systems
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Endovascular Angiography
  11.5.2 Onco-Angiography
  11.5.3 Coronary Angiography
  11.5.4 Neuro-Angiography
 11.6 Historic and Forecasted Market Size By Indication
  11.6.1 Valvular Heart Disease
  11.6.2 Congestive Heart Failure
  11.6.3 Coronary Artery Disease
  11.6.4 Congenital Heart Disease
  11.6.5 Others
 11.7 Historic and Forecasted Market Size By End-User
  11.7.1 Specialty Clinics
  11.7.2 Hospitals
  11.7.3 Diagnostic and Imaging Centers
  11.7.4 Academic and Research Institutes
 11.8 Historic and Forecast Market Size by Country
  11.8.1 U.S.
  11.8.2 Canada
  11.8.3 Mexico

Chapter 12: Europe Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Technology
  12.4.1 X-ray Angiography Systems
  12.4.2 CT Angiography Systems
  12.4.3 MR Angiography Systems
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Endovascular Angiography
  12.5.2 Onco-Angiography
  12.5.3 Coronary Angiography
  12.5.4 Neuro-Angiography
 12.6 Historic and Forecasted Market Size By Indication
  12.6.1 Valvular Heart Disease
  12.6.2 Congestive Heart Failure
  12.6.3 Coronary Artery Disease
  12.6.4 Congenital Heart Disease
  12.6.5 Others
 12.7 Historic and Forecasted Market Size By End-User
  12.7.1 Specialty Clinics
  12.7.2 Hospitals
  12.7.3 Diagnostic and Imaging Centers
  12.7.4 Academic and Research Institutes
 12.8 Historic and Forecast Market Size by Country
  12.8.1 Germany
  12.8.2 U.K.
  12.8.3 France
  12.8.4 Italy
  12.8.5 Russia
  12.8.6 Spain
  12.8.7 Rest of Europe

Chapter 13: Asia-Pacific Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Technology
  13.4.1 X-ray Angiography Systems
  13.4.2 CT Angiography Systems
  13.4.3 MR Angiography Systems
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Endovascular Angiography
  13.5.2 Onco-Angiography
  13.5.3 Coronary Angiography
  13.5.4 Neuro-Angiography
 13.6 Historic and Forecasted Market Size By Indication
  13.6.1 Valvular Heart Disease
  13.6.2 Congestive Heart Failure
  13.6.3 Coronary Artery Disease
  13.6.4 Congenital Heart Disease
  13.6.5 Others
 13.7 Historic and Forecasted Market Size By End-User
  13.7.1 Specialty Clinics
  13.7.2 Hospitals
  13.7.3 Diagnostic and Imaging Centers
  13.7.4 Academic and Research Institutes
 13.8 Historic and Forecast Market Size by Country
  13.8.1 China
  13.8.2 India
  13.8.3 Japan
  13.8.4 Singapore
  13.8.5 Australia
  13.8.6 New Zealand
  13.8.7 Rest of APAC

Chapter 14: Middle East & Africa Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Technology
  14.4.1 X-ray Angiography Systems
  14.4.2 CT Angiography Systems
  14.4.3 MR Angiography Systems
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Endovascular Angiography
  14.5.2 Onco-Angiography
  14.5.3 Coronary Angiography
  14.5.4 Neuro-Angiography
 14.6 Historic and Forecasted Market Size By Indication
  14.6.1 Valvular Heart Disease
  14.6.2 Congestive Heart Failure
  14.6.3 Coronary Artery Disease
  14.6.4 Congenital Heart Disease
  14.6.5 Others
 14.7 Historic and Forecasted Market Size By End-User
  14.7.1 Specialty Clinics
  14.7.2 Hospitals
  14.7.3 Diagnostic and Imaging Centers
  14.7.4 Academic and Research Institutes
 14.8 Historic and Forecast Market Size by Country
  14.8.1 Turkey
  14.8.2 Saudi Arabia
  14.8.3 Iran
  14.8.4 UAE
  14.8.5 Africa
  14.8.6 Rest of MEA

Chapter 15: South America Robotic Angiography Systems Market Analysis, Insights and Forecast, 2016-2028
 15.1 Key Market Trends, Growth Factors and Opportunities
 15.2 Impact of Covid-19
 15.3 Key Players
 15.4 Key Market Trends, Growth Factors and Opportunities
 15.4 Historic and Forecasted Market Size By Technology
  15.4.1 X-ray Angiography Systems
  15.4.2 CT Angiography Systems
  15.4.3 MR Angiography Systems
 15.5 Historic and Forecasted Market Size By Application
  15.5.1 Endovascular Angiography
  15.5.2 Onco-Angiography
  15.5.3 Coronary Angiography
  15.5.4 Neuro-Angiography
 15.6 Historic and Forecasted Market Size By Indication
  15.6.1 Valvular Heart Disease
  15.6.2 Congestive Heart Failure
  15.6.3 Coronary Artery Disease
  15.6.4 Congenital Heart Disease
  15.6.5 Others
 15.7 Historic and Forecasted Market Size By End-User
  15.7.1 Specialty Clinics
  15.7.2 Hospitals
  15.7.3 Diagnostic and Imaging Centers
  15.7.4 Academic and Research Institutes
 15.8 Historic and Forecast Market Size by Country
  15.8.1 Brazil
  15.8.2 Argentina
  15.8.3 Rest of SA

Chapter 16 Investment Analysis

Chapter 17 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY TECHNOLOGY
TABLE 008. X-RAY ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. CT ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. MR ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 011. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY APPLICATION
TABLE 012. ENDOVASCULAR ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 013. ONCO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 014. CORONARY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 015. NEURO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
TABLE 016. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY INDICATION
TABLE 017. VALVULAR HEART DISEASE MARKET OVERVIEW (2016-2028)
TABLE 018. CONGESTIVE HEART FAILURE MARKET OVERVIEW (2016-2028)
TABLE 019. CORONARY ARTERY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 020. CONGENITAL HEART DISEASE MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET BY END-USER
TABLE 023. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 024. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 025. DIAGNOSTIC AND IMAGING CENTERS MARKET OVERVIEW (2016-2028)
TABLE 026. ACADEMIC AND RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
TABLE 027. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 028. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 030. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 031. N ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 032. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 033. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 034. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 035. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 036. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 037. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 038. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 039. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 040. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 041. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 042. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 043. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 044. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 045. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 046. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 047. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY TECHNOLOGY (2016-2028)
TABLE 048. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 049. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY INDICATION (2016-2028)
TABLE 050. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY END-USER (2016-2028)
TABLE 051. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 052. GE HEALTHCARE (US): SNAPSHOT
TABLE 053. GE HEALTHCARE (US): BUSINESS PERFORMANCE
TABLE 054. GE HEALTHCARE (US): PRODUCT PORTFOLIO
TABLE 055. GE HEALTHCARE (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. KUKA (GERMANY): SNAPSHOT
TABLE 056. KUKA (GERMANY): BUSINESS PERFORMANCE
TABLE 057. KUKA (GERMANY): PRODUCT PORTFOLIO
TABLE 058. KUKA (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): SNAPSHOT
TABLE 059. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): BUSINESS PERFORMANCE
TABLE 060. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): PRODUCT PORTFOLIO
TABLE 061. SIEMENS HEALTHCARE PRIVATE LIMITED (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. CORINDUS INC.: SNAPSHOT
TABLE 062. CORINDUS INC.: BUSINESS PERFORMANCE
TABLE 063. CORINDUS INC.: PRODUCT PORTFOLIO
TABLE 064. CORINDUS INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. PHILIPS HEALTHCARE (NETHERLANDS): SNAPSHOT
TABLE 065. PHILIPS HEALTHCARE (NETHERLANDS): BUSINESS PERFORMANCE
TABLE 066. PHILIPS HEALTHCARE (NETHERLANDS): PRODUCT PORTFOLIO
TABLE 067. PHILIPS HEALTHCARE (NETHERLANDS): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. ABBOTT (US): SNAPSHOT
TABLE 068. ABBOTT (US): BUSINESS PERFORMANCE
TABLE 069. ABBOTT (US): PRODUCT PORTFOLIO
TABLE 070. ABBOTT (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. SHIMADZU MEDICAL SYSTEMS (JAPAN): SNAPSHOT
TABLE 071. SHIMADZU MEDICAL SYSTEMS (JAPAN): BUSINESS PERFORMANCE
TABLE 072. SHIMADZU MEDICAL SYSTEMS (JAPAN): PRODUCT PORTFOLIO
TABLE 073. SHIMADZU MEDICAL SYSTEMS (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): SNAPSHOT
TABLE 074. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): BUSINESS PERFORMANCE
TABLE 075. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): PRODUCT PORTFOLIO
TABLE 076. CANON MEDICAL SYSTEMS CORPORATION (JAPAN): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. BOSTON SCIENTIFIC CORPORATION (US): SNAPSHOT
TABLE 077. BOSTON SCIENTIFIC CORPORATION (US): BUSINESS PERFORMANCE
TABLE 078. BOSTON SCIENTIFIC CORPORATION (US): PRODUCT PORTFOLIO
TABLE 079. BOSTON SCIENTIFIC CORPORATION (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. ANGIODYNAMICS (US): SNAPSHOT
TABLE 080. ANGIODYNAMICS (US): BUSINESS PERFORMANCE
TABLE 081. ANGIODYNAMICS (US): PRODUCT PORTFOLIO
TABLE 082. ANGIODYNAMICS (US): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. MEDTRONIC PLC (IRELAND): SNAPSHOT
TABLE 083. MEDTRONIC PLC (IRELAND): BUSINESS PERFORMANCE
TABLE 084. MEDTRONIC PLC (IRELAND): PRODUCT PORTFOLIO
TABLE 085. MEDTRONIC PLC (IRELAND): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 086. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 087. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 088. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY TECHNOLOGY
FIGURE 012. X-RAY ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. CT ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. MR ANGIOGRAPHY SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 015. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 016. ENDOVASCULAR ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 017. ONCO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 018. CORONARY ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 019. NEURO-ANGIOGRAPHY MARKET OVERVIEW (2016-2028)
FIGURE 020. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY INDICATION
FIGURE 021. VALVULAR HEART DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 022. CONGESTIVE HEART FAILURE MARKET OVERVIEW (2016-2028)
FIGURE 023. CORONARY ARTERY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 024. CONGENITAL HEART DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY END-USER
FIGURE 027. SPECIALTY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 028. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 029. DIAGNOSTIC AND IMAGING CENTERS MARKET OVERVIEW (2016-2028)
FIGURE 030. ACADEMIC AND RESEARCH INSTITUTES MARKET OVERVIEW (2016-2028)
FIGURE 031. NORTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 032. EUROPE ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 033. ASIA PACIFIC ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 034. MIDDLE EAST & AFRICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 035. SOUTH AMERICA ROBOTIC ANGIOGRAPHY SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)